{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T04:11:01Z","timestamp":1794370261117,"version":"4.9.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012159","name":"Myelin Repair Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012159","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) is a complex, heterogenous disease characterized by inflammation, demyelination, and blood\u2013brain barrier (BBB) permeability. Currently, active disease is determined by physician confirmed relapse or detection of contrast enhancing lesions via MRI indicative of BBB permeability. However, clinical confirmation of active disease can be cumbersome. As such, disease monitoring in MS could benefit from identification of an easily accessible biomarker of active disease. We believe extracellular vesicles (EV) isolated from plasma are excellent candidates to fulfill this need. Because of the critical role BBB permeability plays in MS pathogenesis and identification of active disease, we sought to identify EV originating from central nervous system (CNS) endothelial as biomarkers of active MS. Because endothelial cells secrete more EV when stimulated or injured, we hypothesized that circulating concentrations of CNS endothelial derived EV will be increased in MS patients with active disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To test this, we developed a novel method to identify EV originating from CNS endothelial cells isolated from patient plasma using flow cytometry. Endothelial derived EV were identified by the absence of lymphocyte or platelet markers CD3 and CD41, respectively, and positive expression of pan-endothelial markers CD31, CD105, or CD144. To determine if endothelial derived EV originated from CNS endothelial cells, EV expressing CD31, CD105, or CD144 were evaluated for expression of the myelin and lymphocyte protein MAL, a protein specifically expressed by CNS endothelial cells compared to endothelial cells of peripheral organs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Quality control experiments indicate that EV detected using our flow cytometry method are 0.2 to 1 micron in size. Flow cytometry analysis of EV isolated from 20 healthy controls, 16 relapsing\u2013remitting MS (RRMS) patients with active disease not receiving disease modifying therapy, 14 RRMS patients with stable disease not receiving disease modifying therapy, 17 relapsing-RRMS patients with stable disease receiving natalizumab, and 14 RRMS patients with stable disease receiving ocrelizumab revealed a significant increase in the plasma concentration of CNS endothelial derived EV in patients with active disease compared to all other groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Conclusions: For the first time, we have identified a method to identify CNS endothelial derived EV in circulation from human blood samples. Results from our pilot study indicate that increased levels of CNS endothelial derived EV may be a biomarker of BBB permeability and active disease in MS.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12987-021-00299-4","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T04:06:44Z","timestamp":1644293204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis"],"prefix":"10.1186","volume":"19","author":[{"given":"Michael","family":"Mazzucco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Mannheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha V.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3852-928X","authenticated-orcid":false,"given":"Jennifer R.","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"issue":"7","key":"299_CR1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/cells8070727","volume":"8","author":"LM Doyle","year":"2019","unstructured":"Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8(7):727.","journal-title":"Cells"},{"key":"299_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255\u201389.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"5","key":"299_CR3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","volume":"12","author":"SE Andaloussi","year":"2013","unstructured":"Andaloussi SE, M\u00e4ger I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12(5):347\u201357.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"299_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"299_CR5","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Thery","year":"2018","unstructured":"Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles"},{"key":"299_CR6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuroscience.2018.04.003","volume":"405","author":"RC Paolicelli","year":"2019","unstructured":"Paolicelli RC, Bergamini G, Rajendran L. Cell-to-cell communication by extracellular vesicles: focus on microglia. Neuroscience. 2019;405:148\u201357.","journal-title":"Neuroscience"},{"issue":"9","key":"299_CR7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41580-019-0158-7","volume":"20","author":"G Raposo","year":"2019","unstructured":"Raposo G, Stahl PD. Extracellular vesicles: a new communication paradigm? Nat Rev Mol Cell Biol. 2019;20(9):509\u201310.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"299_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","volume":"21","author":"M Mathieu","year":"2019","unstructured":"Mathieu M, Martin-Jaular L, Lavieu G, Thery C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21(1):9\u201317.","journal-title":"Nat Cell Biol"},{"key":"299_CR9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fcell.2018.00018","volume":"6","author":"J Maia","year":"2018","unstructured":"Maia J, Caja S, Strano Moraes MC, Couto N, Costa-Silva B. Exosome-based cell-cell communication in the tumor microenvironment. Front Cell Dev Biol. 2018;6:18.","journal-title":"Front Cell Dev Biol"},{"key":"299_CR10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fncel.2014.00100","volume":"8","author":"M Saenz-Cuesta","year":"2014","unstructured":"Saenz-Cuesta M, Osorio-Querejeta I, Otaegui D. Extracellular vesicles in multiple sclerosis: what are they telling us? Front Cell Neurosci. 2014;8:100.","journal-title":"Front Cell Neurosci"},{"issue":"19","key":"299_CR11","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.3390\/ijms21197336","volume":"21","author":"E Dolcetti","year":"2020","unstructured":"Dolcetti E, Bruno A, Guadalupi L, Rizzo FR, Musella A, Gentile A, et al. Emerging role of extracellular vesicles in the pathophysiology of multiple sclerosis. Int J Mol Sci. 2020;21(19):7336.","journal-title":"Int J Mol Sci"},{"key":"299_CR12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fneur.2018.00604","volume":"9","author":"M Blonda","year":"2018","unstructured":"Blonda M, Amoruso A, Martino T, Avolio C. New insights into immune cell-derived extracellular vesicles in multiple sclerosis. Front Neurol. 2018;9:604.","journal-title":"Front Neurol"},{"key":"299_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-47861-6_1","volume":"958","author":"MM Barreca","year":"2017","unstructured":"Barreca MM, Aliotta E, Geraci F. Extracellular vesicles in multiple sclerosis as possible biomarkers: dream or reality? Adv Exp Med Biol. 2017;958:1\u20139.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"299_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","volume":"133","author":"T Kuhlmann","year":"2017","unstructured":"Kuhlmann T, Ludwin S, Prat A, Antel J, Bruck W, Lassmann H. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 2017;133(1):13\u201324.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"299_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrn3900","volume":"16","author":"M Calabrese","year":"2015","unstructured":"Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJ, Reynolds R, Martin R. Exploring the origins of grey matter damage in multiple sclerosis. Nat Rev Neurosci. 2015;16(3):147\u201358.","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"299_CR16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15(9):545\u201358.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"299_CR17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","volume":"17","author":"H Lassmann","year":"2007","unstructured":"Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007;17(2):210\u20138.","journal-title":"Brain Pathol"},{"issue":"2","key":"299_CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","volume":"14","author":"DH Mahad","year":"2015","unstructured":"Mahad DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015;14(2):183\u201393.","journal-title":"Lancet Neurol"},{"issue":"2","key":"299_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-011-0840-0","volume":"122","author":"R Reynolds","year":"2011","unstructured":"Reynolds R, Roncaroli F, Nicholas R, Radotra B, Gveric D, Howell O. The neuropathological basis of clinical progression in multiple sclerosis. Acta Neuropathol. 2011;122(2):155\u201370.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"299_CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G. Multiple sclerosis\u2014a review. Eur J Neurol. 2019;26(1):27\u201340.","journal-title":"Eur J Neurol"},{"issue":"1","key":"299_CR21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2990.2000.00217.x","volume":"26","author":"P van der Valk","year":"2000","unstructured":"van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol. 2000;26(1):2\u201310.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"299_CR22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47(6):707\u201317.","journal-title":"Ann Neurol"},{"issue":"5","key":"299_CR23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ana.24163","volume":"75","author":"I Metz","year":"2014","unstructured":"Metz I, Weigand SD, Popescu BF, Frischer JM, Parisi JE, Guo Y, et al. Pathologic heterogeneity persists in early active multiple sclerosis lesions. Ann Neurol. 2014;75(5):728\u201338.","journal-title":"Ann Neurol"},{"issue":"11","key":"299_CR24","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1007\/s00415-018-9048-8","volume":"265","author":"L Gaetani","year":"2018","unstructured":"Gaetani L, Prosperini L, Mancini A, Eusebi P, Cerri MC, Pozzilli C, et al. 2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes. J Neurol. 2018;265(11):2684\u20137.","journal-title":"J Neurol"},{"issue":"2","key":"299_CR25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373.","journal-title":"Lancet Neurol"},{"issue":"10130","key":"299_CR26","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018;391(10130):1622\u201336.","journal-title":"Lancet"},{"issue":"7","key":"299_CR27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1177\/1352458520911174","volume":"26","author":"C Granziera","year":"2020","unstructured":"Granziera C, Reich DS. Gadolinium should always be used to assess disease activity in MS\u2014Yes. Mult Scler. 2020;26(7):765\u20136.","journal-title":"Mult Scler"},{"issue":"5","key":"299_CR28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.410420515","volume":"42","author":"W Bruck","year":"1997","unstructured":"Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol. 1997;42(5):783\u201393.","journal-title":"Ann Neurol"},{"issue":"5","key":"299_CR29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ana.410340507","volume":"34","author":"D Katz","year":"1993","unstructured":"Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol. 1993;34(5):661\u20139.","journal-title":"Ann Neurol"},{"issue":"4","key":"299_CR30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nic.2008.06.005","volume":"18","author":"H Lassmann","year":"2008","unstructured":"Lassmann H. The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin N Am. 2008;18(4):563\u201376, ix.","journal-title":"Neuroimaging Clin N Am"},{"issue":"9","key":"299_CR31","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1212\/01.wnl.0000210506.00078.5c","volume":"66","author":"DK Li","year":"2006","unstructured":"Li DK, Held U, Petkau J, Daumer M, Barkhof F, Fazekas F, et al. MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology. 2006;66(9):1384\u20139.","journal-title":"Neurology"},{"issue":"11","key":"299_CR32","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1212\/WNL.44.11.2120","volume":"44","author":"SJ Khoury","year":"1994","unstructured":"Khoury SJ, Guttmann CR, Orav EJ, Hohol MJ, Ahn SS, Hsu L, et al. Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology. 1994;44(11):2120\u20134.","journal-title":"Neurology"},{"issue":"4","key":"299_CR33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/135245859900500415","volume":"5","author":"F Barkhof","year":"1999","unstructured":"Barkhof F. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler. 1999;5(4):283\u20136.","journal-title":"Mult Scler"},{"issue":"2","key":"299_CR34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.26154","volume":"90","author":"S Gelibter","year":"2021","unstructured":"Gelibter S, Pisa M, Croese T, Finardi A, Mandelli A, Sangalli F, et al. Spinal fluid myeloid microvesicles predict disease course in multiple sclerosis. Ann Neurol. 2021;90(2):253\u201365.","journal-title":"Ann Neurol"},{"issue":"4","key":"299_CR35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.23627","volume":"72","author":"C Verderio","year":"2012","unstructured":"Verderio C, Muzio L, Turola E, Bergami A, Novellino L, Ruffini F, et al. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann Neurol. 2012;72(4):610\u201324.","journal-title":"Ann Neurol"},{"key":"299_CR36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3389\/fncel.2018.00418","volume":"12","author":"F Geraci","year":"2018","unstructured":"Geraci F, Ragonese P, Barreca MM, Aliotta E, Mazzola MA, Realmuto S, et al. Differences in intercellular communication during clinical relapse and gadolinium-enhanced MRI in patients with relapsing remitting multiple sclerosis: a study of the composition of extracellular vesicles in cerebrospinal fluid. Front Cell Neurosci. 2018;12:418.","journal-title":"Front Cell Neurosci"},{"key":"299_CR37","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3389\/fneur.2019.01241","volume":"10","author":"R Masvekar","year":"2019","unstructured":"Masvekar R, Mizrahi J, Park J, Williamson PR, Bielekova B. Quantifications of CSF apoptotic bodies do not provide clinical value in multiple sclerosis. Front Neurol. 2019;10:1241.","journal-title":"Front Neurol"},{"key":"299_CR38","doi-asserted-by":"crossref","first-page":"103403","DOI":"10.1016\/j.jprot.2019.103403","volume":"204","author":"D Pieragostino","year":"2019","unstructured":"Pieragostino D, Lanuti P, Cicalini I, Cufaro MC, Ciccocioppo F, Ronci M, et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. J Proteomics. 2019;204:103403.","journal-title":"J Proteomics"},{"issue":"10","key":"299_CR39","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1177\/1352458520987542","volume":"27","author":"G Dalla Costa","year":"2021","unstructured":"Dalla Costa G, Croese T, Pisa M, Finardi A, Fabbella L, Martinelli V, et al. CSF extracellular vesicles and risk of disease activity after a first demyelinating event. Mult Scler. 2021;27(10):1606\u201310.","journal-title":"Mult Scler"},{"issue":"2","key":"299_CR40","first-page":"93","volume":"83","author":"CM Doherty","year":"2014","unstructured":"Doherty CM, Forbes RB. Diagnostic lumbar puncture. Ulster Med J. 2014;83(2):93\u2013102.","journal-title":"Ulster Med J"},{"issue":"1","key":"299_CR41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0733-8619(05)70368-6","volume":"16","author":"RW Evans","year":"1998","unstructured":"Evans RW. Complications of lumbar puncture. Neurol Clin. 1998;16(1):83\u2013105.","journal-title":"Neurol Clin"},{"issue":"5","key":"299_CR42","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3174\/ajnr.A7009","volume":"42","author":"A Grayev","year":"2021","unstructured":"Grayev A, Schoepp M, Kuner A. A systematic review of procedural complications from transforaminal lumbar puncture for intrathecal nusinersen administration in patients with spinal muscular atrophy. AJNR Am J Neuroradiol. 2021;42(5):980\u20135.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"18","key":"299_CR43","first-page":"1834","volume":"130","author":"M Pitkanen","year":"2014","unstructured":"Pitkanen M, Forster J. Complications caused by lumbar puncture. Duodecim. 2014;130(18):1834\u201342.","journal-title":"Duodecim"},{"key":"299_CR44","doi-asserted-by":"crossref","first-page":"102446","DOI":"10.1016\/j.msard.2020.102446","volume":"45","author":"K Groen","year":"2020","unstructured":"Groen K, Maltby VE, Scott RJ, Tajouri L, Lechner-Scott J. Concentrations of plasma-borne extracellular particles differ between multiple sclerosis disease courses and compared to healthy controls. Mult Scler Relat Disord. 2020;45:102446.","journal-title":"Mult Scler Relat Disord."},{"issue":"9","key":"299_CR45","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/cells8091058","volume":"8","author":"P Bhargava","year":"2019","unstructured":"Bhargava P, Nogueras-Ortiz C, Chawla S, Baek R, Jorgensen MM, Kapogiannis D. Altered levels of toll-like receptors in circulating extracellular vesicles in multiple sclerosis. Cells. 2019;8(9):1058.","journal-title":"Cells"},{"issue":"4","key":"299_CR46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/1352458520924590","volume":"27","author":"P Bhargava","year":"2021","unstructured":"Bhargava P, Nogueras-Ortiz C, Kim S, Delgado-Peraza F, Calabresi PA, Kapogiannis D. Synaptic and complement markers in extracellular vesicles in multiple sclerosis. Mult Scler. 2021;27(4):509\u201318.","journal-title":"Mult Scler"},{"issue":"4","key":"299_CR47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1352458517696597","volume":"24","author":"G Galazka","year":"2018","unstructured":"Galazka G, Mycko MP, Selmaj I, Raine CS, Selmaj KW. Multiple sclerosis: serum-derived exosomes express myelin proteins. Mult Scler. 2018;24(4):449\u201358.","journal-title":"Mult Scler"},{"issue":"12","key":"299_CR48","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/jnr.23899","volume":"94","author":"AL Moyano","year":"2016","unstructured":"Moyano AL, Li G, Boullerne AI, Feinstein DL, Hartman E, Skias D, et al. Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients. J Neurosci Res. 2016;94(12):1579\u201387.","journal-title":"J Neurosci Res"},{"issue":"5","key":"299_CR49","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/bmm.14.9","volume":"8","author":"M Saenz-Cuesta","year":"2014","unstructured":"Saenz-Cuesta M, Irizar H, Castillo-Trivino T, Munoz-Culla M, Osorio-Querejeta I, Prada A, et al. Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis. Biomark Med. 2014;8(5):653\u201361.","journal-title":"Biomark Med"},{"key":"299_CR50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1742-2094-8-43","volume":"8","author":"M Lowery-Nordberg","year":"2011","unstructured":"Lowery-Nordberg M, Eaton E, Gonzalez-Toledo E, Harris MK, Chalamidas K, McGee-Brown J, et al. The effects of high dose interferon-beta1a on plasma microparticles: correlation with MRI parameters. J Neuroinflammation. 2011;8:43.","journal-title":"J Neuroinflammation"},{"key":"299_CR51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2202-15-110","volume":"15","author":"B Marcos-Ramiro","year":"2014","unstructured":"Marcos-Ramiro B, Oliva Nacarino P, Serrano-Pertierra E, Blanco-Gelaz MA, Weksler BB, Romero IA, et al. Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function. BMC Neurosci. 2014;15:110.","journal-title":"BMC Neurosci"},{"issue":"1\u20132","key":"299_CR52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jns.2015.05.027","volume":"355","author":"JS Alexander","year":"2015","unstructured":"Alexander JS, Chervenak R, Weinstock-Guttman B, Tsunoda I, Ramanathan M, Martinez N, et al. Blood circulating microparticle species in relapsing-remitting and secondary progressive multiple sclerosis. A case-control, cross sectional study with conventional MRI and advanced iron content imaging outcomes. J Neurol Sci. 2015;355(1\u20132):84\u20139.","journal-title":"J Neurol Sci"},{"issue":"14","key":"299_CR53","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1177\/1352458516636959","volume":"22","author":"A Zinger","year":"2016","unstructured":"Zinger A, Latham SL, Combes V, Byrne S, Barnett MH, Hawke S, et al. Plasma levels of endothelial and B-cell-derived microparticles are restored by fingolimod treatment in multiple sclerosis patients. Mult Scler. 2016;22(14):1883\u20137.","journal-title":"Mult Scler"},{"key":"299_CR54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-3-23","volume":"3","author":"WA Sheremata","year":"2006","unstructured":"Sheremata WA, Jy W, Delgado S, Minagar A, McLarty J, Ahn Y. Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis. J Neuroinflammation. 2006;3:23.","journal-title":"J Neuroinflammation"},{"key":"299_CR55","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2741\/1466","volume":"9","author":"W Jy","year":"2004","unstructured":"Jy W, Minagar A, Jimenez JJ, Sheremata WA, Mauro LM, Horstman LL, et al. Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Front Biosci. 2004;9:3137\u201344.","journal-title":"Front Biosci"},{"issue":"1","key":"299_CR56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.22472","volume":"70","author":"MI Gaitan","year":"2011","unstructured":"Gaitan MI, Shea CD, Evangelou IE, Stone RD, Fenton KM, Bielekova B, et al. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol. 2011;70(1):22\u20139.","journal-title":"Ann Neurol"},{"issue":"2","key":"299_CR57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/path.1434","volume":"201","author":"J Kirk","year":"2003","unstructured":"Kirk J, Plumb J, Mirakhur M, McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol. 2003;201(2):319\u201327.","journal-title":"J Pathol"},{"issue":"Pt 1","key":"299_CR58","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/BST0370329","volume":"37","author":"S McQuaid","year":"2009","unstructured":"McQuaid S, Cunnea P, McMahon J, Fitzgerald U. The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis. Biochem Soc Trans. 2009;37(Pt 1):329\u201331.","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"299_CR59","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1191\/1352458503ms965oa","volume":"9","author":"A Minagar","year":"2003","unstructured":"Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler. 2003;9(6):540\u20139.","journal-title":"Mult Scler"},{"issue":"8","key":"299_CR60","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.arcmed.2014.11.013","volume":"45","author":"GG Ortiz","year":"2014","unstructured":"Ortiz GG, Pacheco-Moises FP, Macias-Islas MA, Flores-Alvarado LJ, Mireles-Ramirez MA, Gonzalez-Renovato ED, et al. Role of the blood-brain barrier in multiple sclerosis. Arch Med Res. 2014;45(8):687\u201397.","journal-title":"Arch Med Res"},{"issue":"1","key":"299_CR61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12987-018-0104-7","volume":"15","author":"SH Ramirez","year":"2018","unstructured":"Ramirez SH, Andrews AM, Paul D, Pachter JS. Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers. Fluids Barriers CNS. 2018;15(1):19.","journal-title":"Fluids Barriers CNS"},{"issue":"11","key":"299_CR62","doi-asserted-by":"crossref","first-page":"e1008014","DOI":"10.1371\/journal.ppat.1008014","volume":"15","author":"JR Linden","year":"2019","unstructured":"Linden JR, Flores C, Schmidt EF, Uzal FA, Michel AO, Valenzuela M, et al. Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL. PLoS Pathog. 2019;15(11):e1008014.","journal-title":"PLoS Pathog"},{"issue":"10","key":"299_CR63","doi-asserted-by":"crossref","first-page":"e13741","DOI":"10.1371\/journal.pone.0013741","volume":"5","author":"R Daneman","year":"2010","unstructured":"Daneman R, Zhou L, Agalliu D, Cahoy JD, Kaushal A, Barres BA. The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE. 2010;5(10):e13741.","journal-title":"PLoS ONE"},{"issue":"23","key":"299_CR64","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1073\/pnas.1507125112","volume":"112","author":"S Darmanis","year":"2015","unstructured":"Darmanis S, Sloan SA, Zhang Y, Enge M, Caneda C, Shuer LM, et al. A survey of human brain transcriptome diversity at the single cell level. Proc Natl Acad Sci U S A. 2015;112(23):7285\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"299_CR65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89(1):37\u201353.","journal-title":"Neuron"},{"issue":"1","key":"299_CR66","doi-asserted-by":"crossref","first-page":"12358","DOI":"10.1038\/s41598-020-69096-7","volume":"10","author":"HW Song","year":"2020","unstructured":"Song HW, Foreman KL, Gastfriend BD, Kuo JS, Palecek SP, Shusta EV. Transcriptomic comparison of human and mouse brain microvessels. Sci Rep. 2020;10(1):12358.","journal-title":"Sci Rep"},{"issue":"2","key":"299_CR67","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292\u2013302.","journal-title":"Ann Neurol"},{"issue":"7","key":"299_CR68","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/jth.14154","volume":"16","author":"S Libregts","year":"2018","unstructured":"Libregts S, Arkesteijn GJA, Nemeth A, Nolte-\u2019t Hoen ENM, Wauben MHM. Flow cytometric analysis of extracellular vesicle subsets in plasma: impact of swarm by particles of non-interest. J Thromb Haemost. 2018;16(7):1423\u201336.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"299_CR69","doi-asserted-by":"crossref","first-page":"e12128","DOI":"10.1002\/jev2.12128","volume":"10","author":"RE Veerman","year":"2021","unstructured":"Veerman RE, Teeuwen L, Czarnewski P, Gucluler Akpinar G, Sandberg A, Cao X, et al. Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin. J Extracell Vesicles. 2021;10(9):e12128.","journal-title":"J Extracell Vesicles."},{"issue":"1","key":"299_CR70","doi-asserted-by":"crossref","first-page":"21346","DOI":"10.1038\/s41598-020-78422-y","volume":"10","author":"M Holcar","year":"2020","unstructured":"Holcar M, Ferdin J, Sitar S, Tusek-Znidaric M, Dolzan V, Plemenitas A, et al. Enrichment of plasma extracellular vesicles for reliable quantification of their size and concentration for biomarker discovery. Sci Rep. 2020;10(1):21346.","journal-title":"Sci Rep"},{"key":"299_CR71","doi-asserted-by":"crossref","first-page":"27031","DOI":"10.3402\/jev.v4.27031","volume":"4","author":"RJ Lobb","year":"2015","unstructured":"Lobb RJ, Becker M, Wen SW, Wong CS, Wiegmans AP, Leimgruber A, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J Extracell Vesicles. 2015;4:27031.","journal-title":"J Extracell Vesicles"},{"key":"299_CR72","doi-asserted-by":"crossref","first-page":"31242","DOI":"10.3402\/jev.v5.31242","volume":"5","author":"R Vogel","year":"2016","unstructured":"Vogel R, Coumans FA, Maltesen RG, Boing AN, Bonnington KE, Broekman ML, et al. A standardized method to determine the concentration of extracellular vesicles using tunable resistive pulse sensing. J Extracell Vesicles. 2016;5:31242.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"299_CR73","doi-asserted-by":"crossref","first-page":"1697028","DOI":"10.1080\/20013078.2019.1697028","volume":"9","author":"Y Tian","year":"2020","unstructured":"Tian Y, Gong M, Hu Y, Liu H, Zhang W, Zhang M, et al. Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry. J Extracell Vesicles. 2020;9(1):1697028.","journal-title":"J Extracell Vesicles"},{"issue":"17","key":"299_CR74","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.3390\/ijms21176257","volume":"21","author":"D Lucchetti","year":"2020","unstructured":"Lucchetti D, Battaglia A, Ricciardi-Tenore C, Colella F, Perelli L, De Maria R, et al. Measuring extracellular vesicles by conventional flow cytometry: dream or reality? Int J Mol Sci. 2020;21(17):6257.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"299_CR75","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1538-7836.2012.04683.x","volume":"10","author":"E van der Pol","year":"2012","unstructured":"van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG. Single vs. swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost. 2012;10(5):919\u201330.","journal-title":"J Thromb Haemost"},{"key":"299_CR76","doi-asserted-by":"publisher","DOI":"10.3791\/52484","author":"H Inglis","year":"2015","unstructured":"Inglis H, Norris P, Danesh A. Techniques for the analysis of extracellular vesicles using flow cytometry. J Vis Exp. 2015. https:\/\/doi.org\/10.3791\/52484.","journal-title":"J Vis Exp"},{"issue":"38","key":"299_CR77","doi-asserted-by":"crossref","first-page":"9775","DOI":"10.1039\/C5OB01451D","volume":"13","author":"X Osteikoetxea","year":"2015","unstructured":"Osteikoetxea X, Sodar B, Nemeth A, Szabo-Taylor K, Paloczi K, Vukman KV, et al. Differential detergent sensitivity of extracellular vesicle subpopulations. Org Biomol Chem. 2015;13(38):9775\u201382.","journal-title":"Org Biomol Chem"},{"issue":"4","key":"299_CR78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/antib7040037","volume":"7","author":"JR Linden","year":"2018","unstructured":"Linden JR, Telesford K, Shetty S, Winokour P, Haigh S, Cahir-McFarland E, et al. A novel Panel of rabbit monoclonal antibodies and their diverse applications including inhibition of clostridium perfringens epsilon toxin oligomerization. Antibodies (Basel). 2018;7(4):37.","journal-title":"Antibodies (Basel)."},{"issue":"1","key":"299_CR79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40169-018-0192-7","volume":"7","author":"RE Lane","year":"2018","unstructured":"Lane RE, Korbie D, Hill MM, Trau M. Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges. Clin Transl Med. 2018;7(1):14.","journal-title":"Clin Transl Med"},{"issue":"4","key":"299_CR80","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7150\/ijbs.39629","volume":"16","author":"J Tian","year":"2020","unstructured":"Tian J, Casella G, Zhang Y, Rostami A, Li X. Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases. Int J Biol Sci. 2020;16(4):620\u201332.","journal-title":"Int J Biol Sci"},{"key":"299_CR81","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mam.2017.11.010","volume":"60","author":"F Pardo","year":"2018","unstructured":"Pardo F, Villalobos-Labra R, Sobrevia B, Toledo F, Sobrevia L. Extracellular vesicles in obesity and diabetes mellitus. Mol Aspects Med. 2018;60:81\u201391.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"299_CR82","doi-asserted-by":"crossref","first-page":"1625677","DOI":"10.1080\/20013078.2019.1625677","volume":"8","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Zheng L, Zou X, Wang J, Zhong J, Zhong T. Extracellular vesicles in type 2 diabetes mellitus: key roles in pathogenesis, complications, and therapy. J Extracell Vesicles. 2019;8(1):1625677.","journal-title":"J Extracell Vesicles"},{"issue":"10","key":"299_CR83","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/CIRCRESAHA.117.310752","volume":"120","author":"F Jansen","year":"2017","unstructured":"Jansen F, Nickenig G, Werner N. Extracellular vesicles in cardiovascular disease: potential applications in diagnosis, prognosis, and epidemiology. Circ Res. 2017;120(10):1649\u201357.","journal-title":"Circ Res"},{"issue":"3","key":"299_CR84","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12975-018-0654-7","volume":"10","author":"L Otero-Ortega","year":"2019","unstructured":"Otero-Ortega L, Laso-Garcia F, Gomez-de Frutos M, Fuentes B, Diekhorst L, Diez-Tejedor E, et al. Role of exosomes as a treatment and potential biomarker for stroke. Transl Stroke Res. 2019;10(3):241\u20139.","journal-title":"Transl Stroke Res"},{"issue":"7","key":"299_CR85","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/jth.12602","volume":"12","author":"E van der Pol","year":"2014","unstructured":"van der Pol E, Coumans FA, Grootemaat AE, Gardiner C, Sargent IL, Harrison P, et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost. 2014;12(7):1182\u201392.","journal-title":"J Thromb Haemost"},{"issue":"12","key":"299_CR86","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1111\/j.1538-7836.2010.04074.x","volume":"8","author":"E van der Pol","year":"2010","unstructured":"van der Pol E, Hoekstra AG, Sturk A, Otto C, van Leeuwen TG, Nieuwland R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost. 2010;8(12):2596\u2013607.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"299_CR87","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/jth.14009","volume":"16","author":"E van der Pol","year":"2018","unstructured":"van der Pol E, Sturk A, van Leeuwen T, Nieuwland R, Coumans F, group I-S-VW. Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation. J Thromb Haemost. 2018;16(6):1236\u201345.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"299_CR88","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/jth.12554","volume":"12","author":"N Arraud","year":"2014","unstructured":"Arraud N, Linares R, Tan S, Gounou C, Pasquet JM, Mornet S, et al. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J Thromb Haemost. 2014;12(5):614\u201327.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"299_CR89","doi-asserted-by":"crossref","first-page":"17216","DOI":"10.1038\/s41598-018-35401-8","volume":"8","author":"S Jamaly","year":"2018","unstructured":"Jamaly S, Ramberg C, Olsen R, Latysheva N, Webster P, Sovershaev T, et al. Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using nanoparticle tracking analysis. Sci Rep. 2018;8(1):17216.","journal-title":"Sci Rep"},{"issue":"4","key":"299_CR90","doi-asserted-by":"crossref","first-page":"e0008217","DOI":"10.1371\/journal.pntd.0008217","volume":"14","author":"SR Abbo","year":"2020","unstructured":"Abbo SR, Visser TM, Wang H, Goertz GP, Fros JJ, Abma-Henkens MHC, et al. The invasive Asian bush mosquito Aedes japonicus found in the Netherlands can experimentally transmit Zika virus and Usutu virus. PLoS Negl Trop Dis. 2020;14(4):e0008217.","journal-title":"PLoS Negl Trop Dis"},{"key":"299_CR91","doi-asserted-by":"crossref","unstructured":"Konoshenko MY, Lekchnov EA, Vlassov AV, Laktionov PP. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int 2018; 2018: 8545347.","DOI":"10.1155\/2018\/8545347"},{"issue":"1","key":"299_CR92","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12931-019-1210-z","volume":"20","author":"JM Carnino","year":"2019","unstructured":"Carnino JM, Lee H, Jin Y. Isolation and characterization of extracellular vesicles from Broncho-alveolar lavage fluid: a review and comparison of different methods. Respir Res. 2019;20(1):240.","journal-title":"Respir Res"},{"key":"299_CR93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ymeth.2015.04.008","volume":"87","author":"R Xu","year":"2015","unstructured":"Xu R, Greening DW, Rai A, Ji H, Simpson RJ. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. Methods. 2015;87:11\u201325.","journal-title":"Methods"},{"key":"299_CR94","doi-asserted-by":"crossref","first-page":"25361","DOI":"10.3402\/jev.v3.25361","volume":"3","author":"C Gardiner","year":"2014","unstructured":"Gardiner C, Shaw M, Hole P, Smith J, Tannetta D, Redman CW, et al. Measurement of refractive index by nanoparticle tracking analysis reveals heterogeneity in extracellular vesicles. J Extracell Vesicles. 2014;3:25361.","journal-title":"J Extracell Vesicles"},{"issue":"11","key":"299_CR95","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1021\/nl503371p","volume":"14","author":"E van der Pol","year":"2014","unstructured":"van der Pol E, Coumans FA, Sturk A, Nieuwland R, van Leeuwen TG. Refractive index determination of nanoparticles in suspension using nanoparticle tracking analysis. Nano Lett. 2014;14(11):6195\u2013201.","journal-title":"Nano Lett"},{"issue":"3","key":"299_CR96","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.nano.2017.12.012","volume":"14","author":"E van der Pol","year":"2018","unstructured":"van der Pol E, de Rond L, Coumans FAW, Gool EL, Boing AN, Sturk A, et al. Absolute sizing and label-free identification of extracellular vesicles by flow cytometry. Nanomedicine. 2018;14(3):801\u201310.","journal-title":"Nanomedicine"},{"issue":"3","key":"299_CR97","doi-asserted-by":"crossref","first-page":"e02513","DOI":"10.1128\/mBio.02513-14","volume":"6","author":"JR Linden","year":"2015","unstructured":"Linden JR, Ma Y, Zhao B, Harris JM, Rumah KR, Schaeren-Wiemers N, et al. Clostridium perfringens epsilon toxin causes selective death of mature oligodendrocytes and central nervous system demyelination. MBio. 2015;6(3):e02513.","journal-title":"MBio"},{"issue":"5","key":"299_CR98","doi-asserted-by":"crossref","first-page":"e1004896","DOI":"10.1371\/journal.ppat.1004896","volume":"11","author":"KR Rumah","year":"2015","unstructured":"Rumah KR, Ma Y, Linden JR, Oo ML, Anrather J, Schaeren-Wiemers N, et al. The myelin and lymphocyte protein MAL Is required for binding and activity of Clostridium perfringens epsilon-toxin. PLoS Pathog. 2015;11(5):e1004896.","journal-title":"PLoS Pathog"},{"key":"299_CR99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fncel.2016.00043","volume":"10","author":"AM Andrews","year":"2016","unstructured":"Andrews AM, Lutton EM, Merkel SF, Razmpour R, Ramirez SH. Mechanical injury induces brain endothelial-derived microvesicle release: implications for cerebral vascular injury during traumatic brain injury. Front Cell Neurosci. 2016;10:43.","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"299_CR100","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/ijms22105214","volume":"22","author":"I Figueira","year":"2021","unstructured":"Figueira I, Godinho-Pereira J, Galego S, Maia J, Hasko J, Molnar K, et al. MicroRNAs and extracellular vesicles as distinctive biomarkers of precocious and advanced stages of breast cancer brain metastases development. Int J Mol Sci. 2021;22(10):5214.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"299_CR101","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/s41598-020-64349-x","volume":"10","author":"S Rom","year":"2020","unstructured":"Rom S, Heldt NA, Gajghate S, Seliga A, Reichenbach NL, Persidsky Y. Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles. Sci Rep. 2020;10(1):7274.","journal-title":"Sci Rep"},{"issue":"1","key":"299_CR102","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12974-016-0755-8","volume":"13","author":"D Paul","year":"2016","unstructured":"Paul D, Baena V, Ge S, Jiang X, Jellison ER, Kiprono T, et al. Appearance of claudin-5(+) leukocytes in the central nervous system during neuroinflammation: a novel role for endothelial-derived extracellular vesicles. J Neuroinflammation. 2016;13(1):292.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"299_CR103","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/CIRCRESAHA.117.309419","volume":"120","author":"MC Martinez","year":"2017","unstructured":"Martinez MC, Andriantsitohaina R. Extracellular vesicles in metabolic syndrome. Circ Res. 2017;120(10):1674\u201386.","journal-title":"Circ Res"},{"issue":"6","key":"299_CR104","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jacbts.2017.08.004","volume":"2","author":"F Jansen","year":"2017","unstructured":"Jansen F, Li Q, Pfeifer A, Werner N. Endothelial- and immune cell-derived extracellular vesicles in the regulation of cardiovascular health and disease. JACC Basic Transl Sci. 2017;2(6):790\u2013807.","journal-title":"JACC Basic Transl Sci"},{"issue":"7","key":"299_CR105","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1073\/pnas.84.7.1997","volume":"84","author":"MA Alonso","year":"1987","unstructured":"Alonso MA, Weissman SM. cDNA cloning and sequence of MAL, a hydrophobic protein associated with human T-cell differentiation. Proc Natl Acad Sci U S A. 1987;84(7):1997\u20132001.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"299_CR106","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0301-0082(99)00039-8","volume":"60","author":"M Frank","year":"2000","unstructured":"Frank M. MAL, a proteolipid in glycosphingolipid enriched domains: functional implications in myelin and beyond. Prog Neurobiol. 2000;60(6):531\u201344.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"299_CR107","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1471-4159.1995.65010010.x","volume":"65","author":"N Schaeren-Wiemers","year":"1995","unstructured":"Schaeren-Wiemers N, Schaefer C, Valenzuela DM, Yancopoulos GD, Schwab ME. Identification of new oligodendrocyte- and myelin-specific genes by a differential screening approach. J Neurochem. 1995;65(1):10\u201322.","journal-title":"J Neurochem"},{"issue":"8","key":"299_CR108","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1523\/JNEUROSCI.15-08-05753.1995","volume":"15","author":"N Schaeren-Wiemers","year":"1995","unstructured":"Schaeren-Wiemers N, Valenzuela DM, Frank M, Schwab ME. Characterization of a rat gene, rMAL, encoding a protein with four hydrophobic domains in central and peripheral myelin. J Neurosci. 1995;15(8):5753\u201364.","journal-title":"J Neurosci"},{"issue":"3","key":"299_CR109","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0014-5793(95)01396-2","volume":"377","author":"D Zacchetti","year":"1995","unstructured":"Zacchetti D, Peranen J, Murata M, Fiedler K, Simons K. VIP17\/MAL, a proteolipid in apical transport vesicles. FEBS Lett. 1995;377(3):465\u20139.","journal-title":"FEBS Lett"},{"issue":"3","key":"299_CR110","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jnr.490420316","volume":"42","author":"T Kim","year":"1995","unstructured":"Kim T, Fiedler K, Madison DL, Krueger WH, Pfeiffer SE. Cloning and characterization of MVP17: a developmentally regulated myelin protein in oligodendrocytes. J Neurosci Res. 1995;42(3):413\u201322.","journal-title":"J Neurosci Res"},{"issue":"3","key":"299_CR111","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1471-4159.2002.00987.x","volume":"82","author":"B Erne","year":"2002","unstructured":"Erne B, Sansano S, Frank M, Schaeren-Wiemers N. Rafts in adult peripheral nerve myelin contain major structural myelin proteins and myelin and lymphocyte protein (MAL) and CD59 as specific markers. J Neurochem. 2002;82(3):550\u201362.","journal-title":"J Neurochem"},{"issue":"2","key":"299_CR112","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1471-4159.1999.0730587.x","volume":"73","author":"M Frank","year":"1999","unstructured":"Frank M, Schaeren-Wiemers N, Schneider R, Schwab ME. Developmental expression pattern of the myelin proteolipid MAL indicates different functions of MAL for immature Schwann cells and in a late step of CNS myelinogenesis. J Neurochem. 1999;73(2):587\u201397.","journal-title":"J Neurochem"},{"issue":"5","key":"299_CR113","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1083\/jcb.200406092","volume":"166","author":"N Schaeren-Wiemers","year":"2004","unstructured":"Schaeren-Wiemers N, Bonnet A, Erb M, Erne B, Bartsch U, Kern F, et al. The raft-associated protein MAL is required for maintenance of proper axon\u2013glia interactions in the central nervous system. J Cell Biol. 2004;166(5):731\u201342.","journal-title":"J Cell Biol"},{"issue":"Pt 1","key":"299_CR114","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj3210247","volume":"321","author":"J Millan","year":"1997","unstructured":"Millan J, Puertollano R, Fan L, Rancano C, Alonso MA. The MAL proteolipid is a component of the detergent-insoluble membrane subdomains of human T-lymphocytes. Biochem J. 1997;321(Pt 1):247\u201352.","journal-title":"Biochem J"},{"issue":"6","key":"299_CR115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jemt.1049","volume":"52","author":"J Caduff","year":"2001","unstructured":"Caduff J, Sansano S, Bonnet A, Suter U, Schaeren-Wiemers N. Characterization of GFP-MAL expression and incorporation in rafts. Microsc Res Tech. 2001;52(6):645\u201355.","journal-title":"Microsc Res Tech"},{"issue":"16","key":"299_CR116","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1091\/mbc.e09-02-0142","volume":"20","author":"LG Magal","year":"2009","unstructured":"Magal LG, Yaffe Y, Shepshelovich J, Aranda JF, de Marco MC, Gaus K, et al. Clustering and lateral concentration of raft lipids by the MAL protein. Mol Biol Cell. 2009;20(16):3751\u201362.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"299_CR117","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1006\/bbrc.1997.6530","volume":"233","author":"J Millan","year":"1997","unstructured":"Millan J, Puertollano R, Fan L, Alonso MA. Caveolin and MAL, two protein components of internal detergent-insoluble membranes, are in distinct lipid microenvironments in MDCK cells. Biochem Biophys Res Commun. 1997;233(3):707\u201312.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"299_CR118","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/BJ20110803","volume":"439","author":"SP Ramnarayanan","year":"2011","unstructured":"Ramnarayanan SP, Tuma PL. MAL, but not MAL2, expression promotes the formation of cholesterol-dependent membrane domains that recruit apical proteins. Biochem J. 2011;439(3):497\u2013504.","journal-title":"Biochem J"},{"key":"299_CR119","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fcell.2016.00084","volume":"4","author":"LN Ventimiglia","year":"2016","unstructured":"Ventimiglia LN, Alonso MA. Biogenesis and function of T cell-derived exosomes. Front Cell Dev Biol. 2016;4:84.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"299_CR120","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4049\/jimmunol.1500891","volume":"195","author":"LN Ventimiglia","year":"2015","unstructured":"Ventimiglia LN, Fernandez-Martin L, Martinez-Alonso E, Anton OM, Guerra M, Martinez-Menarguez JA, et al. Cutting edge: regulation of exosome secretion by the integral MAL protein in T cells. J Immunol. 2015;195(3):810\u20134.","journal-title":"J Immunol"},{"issue":"13","key":"299_CR121","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1084\/jem.20080552","volume":"205","author":"O Anton","year":"2008","unstructured":"Anton O, Batista A, Millan J, Andres-Delgado L, Puertollano R, Correas I, et al. An essential role for the MAL protein in targeting Lck to the plasma membrane of human T lymphocytes. J Exp Med. 2008;205(13):3201\u201313.","journal-title":"J Exp Med"},{"issue":"11","key":"299_CR122","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.4049\/jimmunol.1003771","volume":"186","author":"OM Anton","year":"2011","unstructured":"Anton OM, Andres-Delgado L, Reglero-Real N, Batista A, Alonso MA. MAL protein controls protein sorting at the supramolecular activation cluster of human T lymphocytes. J Immunol. 2011;186(11):6345\u201356.","journal-title":"J Immunol"},{"issue":"10","key":"299_CR123","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1091\/mbc.E15-04-0230","volume":"27","author":"B Wankel","year":"2016","unstructured":"Wankel B, Ouyang J, Guo X, Hadjiolova K, Miller J, Liao Y, et al. Sequential and compartmentalized action of Rabs, SNAREs, and MAL in the apical delivery of fusiform vesicles in urothelial umbrella cells. Mol Biol Cell. 2016;27(10):1621\u201334.","journal-title":"Mol Biol Cell"},{"issue":"5","key":"299_CR124","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.bbi.2005.10.005","volume":"20","author":"S Verma","year":"2006","unstructured":"Verma S, Nakaoke R, Dohgu S, Banks WA. Release of cytokines by brain endothelial cells: a polarized response to lipopolysaccharide. Brain Behav Immun. 2006;20(5):449\u201355.","journal-title":"Brain Behav Immun"},{"key":"299_CR125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1146\/annurev.neuro.22.1.11","volume":"22","author":"LL Rubin","year":"1999","unstructured":"Rubin LL, Staddon JM. The cell biology of the blood-brain barrier. Annu Rev Neurosci. 1999;22:11\u201328.","journal-title":"Annu Rev Neurosci"},{"issue":"19","key":"299_CR126","doi-asserted-by":"crossref","first-page":"e00086-18","DOI":"10.1128\/MCB.00086-18","volume":"38","author":"M Blanch","year":"2018","unstructured":"Blanch M, Dorca-Arevalo J, Not A, Cases M, Gomez de Aranda I, Martinez-Yelamos A, et al. The cytotoxicity of epsilon toxin from Clostridium perfringens on lymphocytes is mediated by mal protein expression. Mol Cell Biol. 2018;38(19):e00086-18.","journal-title":"Mol Cell Biol"},{"key":"299_CR127","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.isci.2019.04.016","volume":"15","author":"D Adler","year":"2019","unstructured":"Adler D, Linden JR, Shetty SV, Ma Y, Bokori-Brown M, Titball RW, et al. Clostridium perfringens epsilon toxin compromises the blood-brain barrier in a humanized Zebrafish model. iScience. 2019;15:39\u201354.","journal-title":"iScience."},{"issue":"10","key":"299_CR128","doi-asserted-by":"crossref","first-page":"e76359","DOI":"10.1371\/journal.pone.0076359","volume":"8","author":"KR Rumah","year":"2013","unstructured":"Rumah KR, Linden J, Fischetti VA, Vartanian T. Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease. PLoS ONE. 2013;8(10):e76359.","journal-title":"PLoS ONE"},{"issue":"13","key":"299_CR129","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1111\/jcmm.15315","volume":"24","author":"Z Geng","year":"2020","unstructured":"Geng Z, Huang J, Kang L, Gao S, Yuan Y, Li Y, et al. Clostridium perfringens epsilon toxin binds to erythrocyte MAL receptors and triggers phosphatidylserine exposure. J Cell Mol Med. 2020;24(13):7341\u201352.","journal-title":"J Cell Mol Med"},{"key":"299_CR130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.toxicon.2021.05.002","volume":"198","author":"Z Geng","year":"2021","unstructured":"Geng Z, Kang L, Huang J, Gao S, Wang J, Yuan Y, et al. Epsilon toxin from Clostridium perfringens induces toxic effects on skin tissues and HaCaT and human epidermal keratinocytes. Toxicon. 2021;198:102\u201310.","journal-title":"Toxicon"},{"key":"299_CR131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.anaerobe.2018.05.011","volume":"53","author":"J Dorca-Arevalo","year":"2018","unstructured":"Dorca-Arevalo J, Blanch M, Pradas M, Blasi J. Epsilon toxin from Clostridium perfringens induces cytotoxicity in FRT thyroid epithelial cells. Anaerobe. 2018;53:43\u20139.","journal-title":"Anaerobe"},{"issue":"1","key":"299_CR132","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13567-020-00748-2","volume":"51","author":"J Dorca-Arevalo","year":"2020","unstructured":"Dorca-Arevalo J, Dorca E, Torrejon-Escribano B, Blanch M, Martin-Satue M, Blasi J. Lung endothelial cells are sensitive to epsilon toxin from Clostridium perfringens. Vet Res. 2020;51(1):27.","journal-title":"Vet Res"},{"issue":"2","key":"299_CR133","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1134\/S0006297920020054","volume":"85","author":"GO Skryabin","year":"2020","unstructured":"Skryabin GO, Komelkov AV, Savelyeva EE, Tchevkina EM. Lipid rafts in exosome biogenesis. Biochemistry (Mosc). 2020;85(2):177\u201391.","journal-title":"Biochemistry (Mosc)"},{"issue":"3","key":"299_CR134","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/biom8030094","volume":"8","author":"H Pollet","year":"2018","unstructured":"Pollet H, Conrard L, Cloos AS, Tyteca D. Plasma membrane lipid domains as platforms for vesicle biogenesis and shedding? Biomolecules. 2018;8(3):94.","journal-title":"Biomolecules"},{"key":"299_CR135","doi-asserted-by":"crossref","first-page":"18936","DOI":"10.3402\/jev.v1i0.18396","volume":"1","author":"OG de Jong","year":"2012","unstructured":"de Jong OG, Verhaar MC, Chen Y, Vader P, Gremmels H, Posthuma G, et al. Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vesicles. 2012;1:18936.","journal-title":"J Extracell Vesicles."},{"issue":"1","key":"299_CR136","doi-asserted-by":"crossref","first-page":"1302705","DOI":"10.1080\/20013078.2017.1302705","volume":"6","author":"V Dozio","year":"2017","unstructured":"Dozio V, Sanchez JC. Characterisation of extracellular vesicle-subsets derived from brain endothelial cells and analysis of their protein cargo modulation after TNF exposure. J Extracell Vesicles. 2017;6(1):1302705.","journal-title":"J Extracell Vesicles"},{"key":"299_CR137","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1038\/srep08505","volume":"5","author":"S Yamamoto","year":"2015","unstructured":"Yamamoto S, Niida S, Azuma E, Yanagibashi T, Muramatsu M, Huang TT, et al. Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes. Sci Rep. 2015;5:8505.","journal-title":"Sci Rep"},{"key":"299_CR138","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3389\/fimmu.2019.01455","volume":"10","author":"JW Yun","year":"2019","unstructured":"Yun JW, Barzegar M, Boyer CJ, Minagar A, Couraud PO, Alexander JS. Brain endothelial cells release apical and basolateral microparticles in response to inflammatory cytokine stimulation: relevance to neuroinflammatory stress? Front Immunol. 2019;10:1455.","journal-title":"Front Immunol"},{"issue":"1","key":"299_CR139","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13041-016-0243-1","volume":"9","author":"Q Pan","year":"2016","unstructured":"Pan Q, He C, Liu H, Liao X, Dai B, Chen Y, et al. Microvascular endothelial cells-derived microvesicles imply in ischemic stroke by modulating astrocyte and blood brain barrier function and cerebral blood flow. Mol Brain. 2016;9(1):63.","journal-title":"Mol Brain"},{"issue":"4","key":"299_CR140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1089\/neu.2017.5049","volume":"35","author":"I Hazelton","year":"2018","unstructured":"Hazelton I, Yates A, Dale A, Roodselaar J, Akbar N, Ruitenberg MJ, et al. Exacerbation of acute traumatic brain injury by circulating extracellular vesicles. J Neurotrauma. 2018;35(4):639\u201351.","journal-title":"J Neurotrauma"},{"issue":"1","key":"299_CR141","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2045-8118-10-4","volume":"10","author":"AS Haqqani","year":"2013","unstructured":"Haqqani AS, Delaney CE, Tremblay TL, Sodja C, Sandhu JK, Stanimirovic DB. Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS. 2013;10(1):4.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"299_CR142","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41467-017-02406-2","volume":"9","author":"K Kimura","year":"2018","unstructured":"Kimura K, Hohjoh H, Fukuoka M, Sato W, Oki S, Tomi C, et al. Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis. Nat Commun. 2018;9(1):17.","journal-title":"Nat Commun"},{"issue":"5","key":"299_CR143","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ana.24931","volume":"81","author":"I Selmaj","year":"2017","unstructured":"Selmaj I, Cichalewska M, Namiecinska M, Galazka G, Horzelski W, Selmaj KW, et al. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol. 2017;81(5):703\u201317.","journal-title":"Ann Neurol"},{"issue":"1","key":"299_CR144","doi-asserted-by":"crossref","first-page":"14293","DOI":"10.1038\/s41598-017-14301-3","volume":"7","author":"S Ebrahimkhani","year":"2017","unstructured":"Ebrahimkhani S, Vafaee F, Young PE, Hur SSJ, Hawke S, Devenney E, et al. Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci Rep. 2017;7(1):14293.","journal-title":"Sci Rep"},{"issue":"3\u20134","key":"299_CR145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12031-017-0977-y","volume":"63","author":"M Niwald","year":"2017","unstructured":"Niwald M, Migdalska-Sek M, Brzezianska-Lasota E, Miller E. Evaluation of selected microRNAs expression in remission phase of multiple sclerosis and their potential link to cognition, depression, and disability. J Mol Neurosci. 2017;63(3\u20134):275\u201382.","journal-title":"J Mol Neurosci"},{"issue":"8","key":"299_CR146","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1096\/fj.201701533R","volume":"32","author":"I Manna","year":"2018","unstructured":"Manna I, Iaccino E, Dattilo V, Barone S, Vecchio E, Mimmi S, et al. Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients. FASEB J. 2018;32(8):4241\u20136.","journal-title":"FASEB J"},{"issue":"8","key":"299_CR147","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.3390\/ijms19082448","volume":"19","author":"M Saenz-Cuesta","year":"2018","unstructured":"Saenz-Cuesta M, Alberro A, Munoz-Culla M, Osorio-Querejeta I, Fernandez-Mercado M, Lopetegui I, et al. The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients. Int J Mol Sci. 2018;19(8):2448.","journal-title":"Int J Mol Sci"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-021-00299-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-021-00299-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-021-00299-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T23:53:48Z","timestamp":1700178828000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-021-00299-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":147,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["299"],"URL":"https:\/\/doi.org\/10.1186\/s12987-021-00299-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-915375\/v1","asserted-by":"object"}]},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"17 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study subjects were recruited and consented according to Weill Cornell Medicine Institutional Review Board\u2013approved protocol 1003010940.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Antibody JL004 used in this publication is the subject of granted and pending patent applications.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}